COVID-19 vaccine franchise focused on vaccine adaptation readiness ahead of the fall season and advancing next generation vaccine candidates and combinationsBioNTech and partner OncoC4 plan to start a
Investegate announcements from BioNTech SE, BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel
JERUSALEM, Israel, March 1, 2023 - BioNTech SE(Nasdaq: BNTX, "BioNTech", "the Company") announced that the Company and the Weizmann Institute of Science ("Weizmann Institute") signed a Memorandum